KTTA

Pasithea Therapeutics Corp

May 20 • 04:00PM ET

0.7220

+0.0194 2.76 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NRXP NERV ADIL ALZN DMAC

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.07	Insider Own	11.37%	Shs Outstand	24.94M	Perf Week	-8.03%
Market Cap	24.13M	Forward P/E	-	EPS next Y	-2.10	Insider Trans	7.59%	Shs Float	22.10M	Perf Month	4.64%
Enterprise Value	-26.37M	PEG	-	EPS next Q	-0.45	Inst Own	70.48%	Short Float	1.21%	Perf Quarter	-9.60%
Income	-19.73M	P/S	-	EPS this Y	36.08%	Inst Trans	27.83%	Short Ratio	0.64	Perf Half Y	-1.11%
Sales	0.00M	P/B	0.33	EPS next Y	-12.90%	ROA	-55.58%	Short Interest	0.27M	Perf YTD	-44.03%
Book/sh	2.20	P/C	0.48	EPS next 5Y	7.54%	ROE	-58.22%	52W High	2.06 -64.95%	Perf Year	-26.13%
Cash/sh	1.51	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.00%	52W Low	0.28 156.94%	Perf 3Y	-89.38%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.35% 7.24%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.42%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	35.40	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.33	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	35.40	EPS Q/Q	92.68%	SMA20	-5.47%	Beta	0.23	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-5.79%	Rel Volume	0.60	Prev Close	0.70
Employees	5	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-11.58%	Avg Volume	416.63K	Price	0.72
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-338.89% -	Trades		Volume	248,505	Change	2.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)